Summarized by Masters of Longevity from Longevity Technology.
Cytonics analyzed a decade of Osteoarthritis Initiative data to guide CYT-108.

Key Takeaways
- Cytonics analyzed ten years of Osteoarthritis Initiative data.
- FOCAL analysis steered candidate selection for the CYT-108 program.
- Observational data does not prove CYT-108 will be effective.



